Rituximab: Current status as therapy for malignant and Benign hematologic disorders

Nihal E. Abdulla, Mary J. Ninan, Avi B. Markowitz

    Research output: Contribution to journal › Review article › peer-review

    14 Scopus citations

    Fingerprint

    Dive into the research topics of 'Rituximab: Current status as therapy for malignant and Benign hematologic disorders'. Together they form a unique fingerprint.

    Keyphrases

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science